CN Patent

CN103961354A — 一种稳定的瑞舒伐他汀钙药物组合物及其制备方法

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2014-08-06 · 12y expired

What this patent protects

本发明提供一种稳定的瑞舒伐他汀钙药物组合物，该药物组合物具有很高的稳定性，含有该药物组合物的片剂在加速实验后总杂含量低于1.0%，其中内酯单杂含量低于0.10%。

USPTO Abstract

本发明提供一种稳定的瑞舒伐他汀钙药物组合物，该药物组合物具有很高的稳定性，含有该药物组合物的片剂在加速实验后总杂含量低于1.0%，其中内酯单杂含量低于0.10%。

Drugs covered by this patent

Patent Metadata

Patent number
CN103961354A
Jurisdiction
CN
Classification
—
Expires
2014-08-06
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Salubris Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.